发明名称 Methods for assessing the suitability of transduced T cells for administration
摘要 The invention relates to of analyzing vector supernatants useful for transducing T cells destined for administration to a human subject. The invention also related to methods of analyzing transduced T cells destined for administration to a human subject.
申请公布号 US9572836(B2) 申请公布日期 2017.02.21
申请号 US201314412844 申请日期 2013.07.12
申请人 The Trustees of the University of Pennsylvania 发明人 June Carl H.;Levine Bruce L.;Kalos Michael D.
分类号 C12Q1/04;A61K35/17;C12Q1/70;G01N33/569;G01N33/92;C07K16/28 主分类号 C12Q1/04
代理机构 Saul Ewing LLP 代理人 Saul Ewing LLP ;Doyle Kathryn
主权项 1. A method of analyzing a composition comprising a genetically modified T cell to detect a contaminant, the method comprises: preparing the composition comprising the genetically modified T cell, wherein the genetically modified T cell comprises a nucleic acid encoding a chimeric antigen receptor (CAR) comprising an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a signaling domain; and analyzing the composition for at least one contaminant selected from the group consisting of a replication competent lentivirus (RCL), p24, a nucleic acid and/or protein derived from a plasmid used to package a lentivirus plasmid, vesicular stomatitis virus G-protein (VSV-G) nucleic acid and/or protein, and human immunodeficiency virus (HIV) gag.
地址 Philadelphia PA US